SG11201503770VA - Pyridine derivative - Google Patents
Pyridine derivativeInfo
- Publication number
- SG11201503770VA SG11201503770VA SG11201503770VA SG11201503770VA SG11201503770VA SG 11201503770V A SG11201503770V A SG 11201503770VA SG 11201503770V A SG11201503770V A SG 11201503770VA SG 11201503770V A SG11201503770V A SG 11201503770VA SG 11201503770V A SG11201503770V A SG 11201503770VA
- Authority
- SG
- Singapore
- Prior art keywords
- pyridine derivative
- pyridine
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012250661 | 2012-11-14 | ||
| PCT/JP2013/080706 WO2014077285A1 (en) | 2012-11-14 | 2013-11-13 | Pyridine derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201503770VA true SG11201503770VA (en) | 2015-06-29 |
Family
ID=50731196
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201503770VA SG11201503770VA (en) | 2012-11-14 | 2013-11-13 | Pyridine derivative |
| SG10201705852PA SG10201705852PA (en) | 2012-11-14 | 2013-11-13 | Pyridine derivative |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201705852PA SG10201705852PA (en) | 2012-11-14 | 2013-11-13 | Pyridine derivative |
Country Status (36)
| Country | Link |
|---|---|
| US (2) | US9637469B2 (en) |
| EP (2) | EP3339302A1 (en) |
| JP (2) | JP5774238B2 (en) |
| KR (1) | KR20150082194A (en) |
| CN (2) | CN104797570B (en) |
| AR (1) | AR093468A1 (en) |
| AU (2) | AU2013345894B2 (en) |
| BR (1) | BR112015010977A2 (en) |
| CA (1) | CA2891408A1 (en) |
| CL (1) | CL2015001279A1 (en) |
| CY (1) | CY1120127T1 (en) |
| DK (1) | DK2944633T3 (en) |
| ES (1) | ES2662444T3 (en) |
| HK (1) | HK1211940A1 (en) |
| HR (1) | HRP20180451T1 (en) |
| HU (1) | HUE037736T2 (en) |
| IL (2) | IL238539A (en) |
| LT (1) | LT2944633T (en) |
| MA (1) | MA38078B1 (en) |
| ME (1) | ME03016B (en) |
| MX (1) | MX2015003672A (en) |
| NO (1) | NO2944633T3 (en) |
| NZ (1) | NZ708031A (en) |
| PE (1) | PE20150974A1 (en) |
| PH (1) | PH12015501037A1 (en) |
| PL (1) | PL2944633T3 (en) |
| PT (1) | PT2944633T (en) |
| RS (1) | RS57090B1 (en) |
| RU (1) | RU2640588C2 (en) |
| SA (1) | SA515360431B1 (en) |
| SG (2) | SG11201503770VA (en) |
| SI (1) | SI2944633T1 (en) |
| TW (1) | TWI666205B (en) |
| UA (1) | UA117359C2 (en) |
| WO (1) | WO2014077285A1 (en) |
| ZA (1) | ZA201503322B (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR100403A1 (en) | 2014-05-13 | 2016-10-05 | Teijin Pharma Ltd | PIRAZINE DERIVATIVES |
| CA2948792A1 (en) * | 2014-05-13 | 2015-11-19 | Teijin Pharma Limited | Novel crystalline polymorphs of pyridine derivative and method for producing the same |
| WO2017157735A1 (en) | 2016-03-15 | 2017-09-21 | Bayer Cropscience Aktiengesellschaft | Substituted sulfonyl amides for controlling animal pests |
| CN107286156A (en) * | 2016-04-05 | 2017-10-24 | 江苏新元素医药科技有限公司 | New URAT1 inhibitor and its in application pharmaceutically |
| CN106008488B (en) * | 2016-05-20 | 2018-10-30 | 广东东阳光药业有限公司 | Cyanoindole analog derivative and its preparation method and application |
| WO2017202291A1 (en) * | 2016-05-23 | 2017-11-30 | 南京明德新药研发股份有限公司 | Thiophene, manufacturing method thereof, and pharmaceutical application of same |
| TW201822637A (en) | 2016-11-07 | 2018-07-01 | 德商拜耳廠股份有限公司 | Substituted sulfonamides for controlling animal pests |
| WO2018130443A1 (en) | 2017-01-10 | 2018-07-19 | Bayer Aktiengesellschaft | Heterocyclene derivatives as pest control agents |
| EP3568392B1 (en) | 2017-01-10 | 2021-02-24 | Bayer Aktiengesellschaft | Imidazole derivatives as pest control agents |
| CN108658879A (en) * | 2017-03-29 | 2018-10-16 | 天津药物研究院有限公司 | A kind of URAT1 inhibitor and its preparation method and application |
| CN109251184B (en) * | 2017-07-13 | 2021-06-15 | 浙江海正药业股份有限公司 | Medical application of 2-trifluoromethyl benzene sulfonamide derivative |
| PL3762368T3 (en) | 2018-03-08 | 2022-06-06 | Incyte Corporation | Aminopyrazine diol compounds as pi3k-y inhibitors |
| US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
| TWI820231B (en) | 2018-10-11 | 2023-11-01 | 德商拜耳廠股份有限公司 | Process for preparing substituted imidazole derivatives |
| CN111943957B (en) * | 2019-05-17 | 2023-01-06 | 中国医学科学院药物研究所 | Quinoline formamide compound and preparation method and application thereof |
| KR20220098170A (en) | 2019-11-07 | 2022-07-11 | 바이엘 악티엔게젤샤프트 | Substituted sulfonyl amides for controlling animal pests |
| KR20230039665A (en) | 2020-07-02 | 2023-03-21 | 바이엘 악티엔게젤샤프트 | Heterocycle derivatives as pest control agents |
| CN114315729B (en) * | 2021-12-09 | 2024-01-26 | 大连理工大学 | 1-benzyl-2, 4-diaryl imidazole compound, synthetic method and application thereof in resisting tumor |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1599032A (en) | 1977-03-04 | 1981-09-30 | May & Baker Ltd | Imidazole derivatives having herbicidal activity |
| JPS5671073A (en) | 1979-11-12 | 1981-06-13 | Takeda Chem Ind Ltd | Imidazole derivative |
| US4770689A (en) * | 1986-03-10 | 1988-09-13 | Janssen Pharmaceutica N.V. | Herbicidal imidazole-5-carboxylic acid derivatives |
| PL149675B1 (en) | 1986-03-10 | 1990-03-31 | Method of obtaining novel derivatives of 1-methyl 1h-imidazolecarboxylic-5 acid | |
| US4851424A (en) | 1986-06-06 | 1989-07-25 | Ciba-Geigy Corporation | 1-Phenyl-lower alkyl-imidazole 4- or 5-carboxamide compounds which are useful in the treatment of epilepsy |
| DD260928A5 (en) | 1986-06-06 | 1988-10-12 | Ciba-Geigy Ag,Ch | PROCESS FOR THE PREPARATION OF NEW ARALKYLIMIDIZOL DERIVATIVES |
| JPH08119936A (en) | 1994-10-18 | 1996-05-14 | Fujisawa Pharmaceut Co Ltd | Heterocyclic derivative |
| IT1295405B1 (en) | 1997-09-30 | 1999-05-12 | Merck Sharp & Dohme Italia S P | USE OF AN ANGIOTENSIN II RECEPTORAL ANTAGONIST FOR DRUG PREPARATION TO INCREASE THE SURVIVAL RATE OF |
| AU2001275794A1 (en) | 2000-07-28 | 2002-02-13 | Sumitomo Pharmaceuticals Co. Ltd. | Pyrrole derivatives |
| US6884896B2 (en) | 2001-02-22 | 2005-04-26 | Teijin Limited | Benzo[b]thiophene derivatives and process for preparing the same |
| AU2003902828A0 (en) * | 2003-06-05 | 2003-06-26 | Fujisawa Pharmaceutical Co., Ltd. | Dpp-iv inhibitor |
| NZ585583A (en) * | 2007-11-27 | 2011-09-30 | Ardea Biosciences Inc | Novel compounds and compositions and methods of use |
| US8450500B2 (en) * | 2008-06-04 | 2013-05-28 | Synta Pharmaceuticals Corp. | Pyrrole compounds that modulate HSP90 activity |
| KR20110050708A (en) | 2008-09-04 | 2011-05-16 | 아디아 바이오사이언스즈 인크. | Compounds, compositions and methods of using same for modulating uric acid levels |
| JP2010202575A (en) | 2009-03-03 | 2010-09-16 | Takeda Chem Ind Ltd | Heterocyclic compound |
| EP2451779B1 (en) * | 2009-07-10 | 2014-09-03 | The General Hospital Corporation | Etomidate analogues that do not inhibit adrenocortical steroid synthesis |
| CN102035579B (en) * | 2009-09-28 | 2014-09-03 | 夏普株式会社 | Information feedback method and user equipment |
| AR081930A1 (en) * | 2010-06-16 | 2012-10-31 | Ardea Biosciences Inc | THIOACETATE COMPOUNDS |
| JP5485811B2 (en) * | 2010-06-23 | 2014-05-07 | 株式会社ジャパンディスプレイ | Bidirectional shift register and image display device using the same |
| AU2011289377A1 (en) | 2010-08-11 | 2013-03-07 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
-
2013
- 2013-11-13 RU RU2015122698A patent/RU2640588C2/en active
- 2013-11-13 UA UAA201505767A patent/UA117359C2/en unknown
- 2013-11-13 JP JP2014547007A patent/JP5774238B2/en not_active Expired - Fee Related
- 2013-11-13 MX MX2015003672A patent/MX2015003672A/en unknown
- 2013-11-13 EP EP18152142.8A patent/EP3339302A1/en not_active Withdrawn
- 2013-11-13 MA MA38078A patent/MA38078B1/en unknown
- 2013-11-13 CN CN201380059519.0A patent/CN104797570B/en not_active Expired - Fee Related
- 2013-11-13 AU AU2013345894A patent/AU2013345894B2/en not_active Ceased
- 2013-11-13 PT PT138547146T patent/PT2944633T/en unknown
- 2013-11-13 HU HUE13854714A patent/HUE037736T2/en unknown
- 2013-11-13 LT LTEP13854714.6T patent/LT2944633T/en unknown
- 2013-11-13 PL PL13854714T patent/PL2944633T3/en unknown
- 2013-11-13 BR BR112015010977A patent/BR112015010977A2/en not_active Application Discontinuation
- 2013-11-13 EP EP13854714.6A patent/EP2944633B1/en active Active
- 2013-11-13 SI SI201330943T patent/SI2944633T1/en unknown
- 2013-11-13 SG SG11201503770VA patent/SG11201503770VA/en unknown
- 2013-11-13 KR KR1020157008457A patent/KR20150082194A/en not_active Application Discontinuation
- 2013-11-13 AR ARP130104172A patent/AR093468A1/en unknown
- 2013-11-13 SG SG10201705852PA patent/SG10201705852PA/en unknown
- 2013-11-13 DK DK13854714.6T patent/DK2944633T3/en active
- 2013-11-13 ES ES13854714T patent/ES2662444T3/en active Active
- 2013-11-13 CN CN201710933918.5A patent/CN107721931A/en active Pending
- 2013-11-13 NZ NZ708031A patent/NZ708031A/en not_active IP Right Cessation
- 2013-11-13 WO PCT/JP2013/080706 patent/WO2014077285A1/en active Application Filing
- 2013-11-13 US US14/441,074 patent/US9637469B2/en active Active
- 2013-11-13 ME MEP-2018-91A patent/ME03016B/en unknown
- 2013-11-13 CA CA2891408A patent/CA2891408A1/en not_active Abandoned
- 2013-11-13 NO NO13854714A patent/NO2944633T3/no unknown
- 2013-11-13 TW TW102141292A patent/TWI666205B/en not_active IP Right Cessation
- 2013-11-13 PE PE2015000616A patent/PE20150974A1/en not_active Application Discontinuation
- 2013-11-13 RS RS20180390A patent/RS57090B1/en unknown
-
2015
- 2015-01-16 JP JP2015007229A patent/JP6293068B2/en not_active Expired - Fee Related
- 2015-04-30 IL IL238539A patent/IL238539A/en not_active IP Right Cessation
- 2015-05-08 PH PH12015501037A patent/PH12015501037A1/en unknown
- 2015-05-12 CL CL2015001279A patent/CL2015001279A1/en unknown
- 2015-05-13 SA SA515360431A patent/SA515360431B1/en unknown
- 2015-05-13 ZA ZA2015/03322A patent/ZA201503322B/en unknown
- 2015-12-17 IL IL243193A patent/IL243193A0/en unknown
- 2015-12-31 HK HK15112873.0A patent/HK1211940A1/en not_active IP Right Cessation
-
2017
- 2017-03-22 US US15/466,088 patent/US20170190694A1/en not_active Abandoned
- 2017-07-07 AU AU2017204665A patent/AU2017204665A1/en not_active Abandoned
-
2018
- 2018-03-16 HR HRP20180451TT patent/HRP20180451T1/en unknown
- 2018-04-10 CY CY20181100389T patent/CY1120127T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20180451T1 (en) | Pyridine derivative | |
| HRP20180672T1 (en) | Novel pyridine derivatives | |
| HK1203504A1 (en) | Pyridone derivative | |
| HK1207375A1 (en) | Piperidinylpyrazolopyridine derivative | |
| IL236295A (en) | Indanesulfamide derivative | |
| HK1200824A1 (en) | Substituted phenylazole derivative | |
| PL2873660T3 (en) | Indolecarboxamide derivative | |
| EP2842958A4 (en) | Naphthobisthiadiazole derivative | |
| HK1206716A1 (en) | Novel pyridine derivatives | |
| HK1204621A1 (en) | 4-alkanoylamino-3-pyrazolone derivative 4--3- |